A W Shand1,2, J S Chen3, W Selby4,5, M Solomon6, C L Roberts3. 1. Clinical and Population Perinatal Health Research, Kolling Institute, University of Sydney, Sydney, NSW, Australia. Antonia.shand@sydney.edu.au. 2. Department of Maternal Fetal Medicine, Royal Hospital for Women, Randwick, NSW, Australia. Antonia.shand@sydney.edu.au. 3. Clinical and Population Perinatal Health Research, Kolling Institute, University of Sydney, Sydney, NSW, Australia. 4. AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. 5. Faculty of Medicine, Central Clinical School, University of Sydney, Sydney, NSW, Australia. 6. SOuRCe (Surgical Outcomes Research Centre), The Institute of Academic Surgery, Royal Prince Alfred Hospital, University of Sydney, Camperdown, Sydney, NSW, Australia.
Abstract
OBJECTIVE: To determine the prevalence of the inflammatory bowel diseases (IBD), ulcerative colitis (UC) and Crohn's disease (CD), in pregnant women and determine pregnancy and fetal/neonatal outcomes. DESIGN: Population-based cohort study. SETTING: New South Wales, Australia, 2001-11. POPULATION: A total of 630 742 women who delivered at ≥20 weeks of gestation. METHODS: Descriptive and multivariate regression analyses of perinatal data linked to hospital admission data. We compared birth outcomes of women with and without a documented diagnosis of IBD. MAIN OUTCOME MEASURES: Caesarean section, severe maternal morbidity, preterm birth <37 weeks of gestation, planned preterm birth, small-for-gestational-age (birthweight <10th centile), perinatal mortality (stillbirth/neonatal death ≤28 days). RESULTS: In all, 1960 women (0.31%) with IBD, who had 2781 births (1183 UC, 1287 CD and 311 IBD-indeterminate). Women with IBD were more likely than women without IBD to have a caesarean section [41.5 versus 28.2%, adjusted risk ratio (aRR) 1.38, 95% CI 1.31-1.45], severe maternal morbidity (2.6 versus 1.6%, aRR 1.54, 95% CI 1.17-2.03), preterm birth (9.7 versus 6.6%, aRR 1.47, 95% CI 1.30-1.66), planned preterm birth (5.3 versus 2.9%, aRR 1.74, 95% CI 1.47-2.07), and their infants to be small-for-gestational-age (9.7 versus 9.5%, aRR 1.19, 95% CI 1.04-1.36). There was no evidence of a difference in perinatal mortality. CONCLUSION: Pregnancy-associated IBD is more common than previously reported. Pregnancies complicated by IBD at or near the time of birth have significantly higher rates of adverse pregnancy outcomes than pregnancies of women without IBD. TWEETABLE ABSTRACT: Increased rates preterm birth and caesarean section in women with inflammatory bowel disease.
OBJECTIVE: To determine the prevalence of the inflammatory bowel diseases (IBD), ulcerative colitis (UC) and Crohn's disease (CD), in pregnant women and determine pregnancy and fetal/neonatal outcomes. DESIGN: Population-based cohort study. SETTING: New South Wales, Australia, 2001-11. POPULATION: A total of 630 742 women who delivered at ≥20 weeks of gestation. METHODS: Descriptive and multivariate regression analyses of perinatal data linked to hospital admission data. We compared birth outcomes of women with and without a documented diagnosis of IBD. MAIN OUTCOME MEASURES: Caesarean section, severe maternal morbidity, preterm birth <37 weeks of gestation, planned preterm birth, small-for-gestational-age (birthweight <10th centile), perinatal mortality (stillbirth/neonatal death ≤28 days). RESULTS: In all, 1960 women (0.31%) with IBD, who had 2781 births (1183 UC, 1287 CD and 311 IBD-indeterminate). Women with IBD were more likely than women without IBD to have a caesarean section [41.5 versus 28.2%, adjusted risk ratio (aRR) 1.38, 95% CI 1.31-1.45], severe maternal morbidity (2.6 versus 1.6%, aRR 1.54, 95% CI 1.17-2.03), preterm birth (9.7 versus 6.6%, aRR 1.47, 95% CI 1.30-1.66), planned preterm birth (5.3 versus 2.9%, aRR 1.74, 95% CI 1.47-2.07), and their infants to be small-for-gestational-age (9.7 versus 9.5%, aRR 1.19, 95% CI 1.04-1.36). There was no evidence of a difference in perinatal mortality. CONCLUSION: Pregnancy-associated IBD is more common than previously reported. Pregnancies complicated by IBD at or near the time of birth have significantly higher rates of adverse pregnancy outcomes than pregnancies of women without IBD. TWEETABLE ABSTRACT: Increased rates preterm birth and caesarean section in women with inflammatory bowel disease.
Authors: Chelsey J F Smith; Kenneth L Jones; Diana L Johnson; Gretchen Bandoli; Loan K Robinson; Arthur Kavanaugh; Christina D Chambers Journal: Am J Med Genet A Date: 2018-01-17 Impact factor: 2.802
Authors: Kristin Palmsten; Dani Bredesen; Meghan M JaKa; Pritika C Kumar; Jeanette Y Ziegenfuss; Elyse O Kharbanda Journal: Pharmacoepidemiol Drug Saf Date: 2020-12-22 Impact factor: 2.890
Authors: Bhavi P Modi; Maria E Teves; Laurel N Pearson; Hardik I Parikh; Hannah Haymond-Thornburg; John L Tucker; Piya Chaemsaithong; Nardhy Gomez-Lopez; Timothy P York; Roberto Romero; Jerome F Strauss Journal: Mol Genet Genomic Med Date: 2017-08-23 Impact factor: 2.183
Authors: Lisa M Korst; Kimberly D Gregory; Lisa A Nicholas; Samia Saeb; David J Reynen; Jennifer L Troyan; Naomi Greene; Moshe Fridman Journal: Matern Health Neonatol Perinatol Date: 2021-01-06
Authors: Jill Hahn; Diane R Gold; Brent A Coull; Marie C McCormick; Patricia W Finn; David L Perkins; Sheryl L Rifas Shiman; Emily Oken; Laura D Kubzansky Journal: Int J Environ Res Public Health Date: 2021-05-11 Impact factor: 3.390